Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 1R01NS140610-01

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2025
    2029
  • Known Financial Commitments (USD)

    $654,367
  • Funder

    National Institutes of Health (NIH)
  • Principal Investigator

    ASSISTANT PROFESSOR Vikram Chib
  • Research Location

    United States of America
  • Lead Research Institution

    HUGO W. MOSER RES INST KENNEDY KRIEGER
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Post acute and long term health consequences

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

PROJECT SUMMARY Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) and has led to a global pandemic, infecting more than 760 million people worldwide. Although COVID-19 was initially described as a respiratory disease, there is growing evidence that SARS-CoV-2 impacts the nervous system and causes impairments that may last long after the acute phase of the disease. This spectrum of persistent symptoms is called Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) or Long COVID. Physical fatigue is one of the most common symptoms associated with PASC, yet there is a limited understanding of its behavioral and neural mechanisms. Neuroinflammation is thought to be a primary contributor to feelings of fatigue in many neurological disorders, including PASC, and brain blood-brain barrier (BBB) injury is a hallmark of neuroinflammation. Despite the potential links between PASC, BBB dysfunction, and fatigue, their relationship has yet to be studied. To this end, we will use a combination of experiments in human participants, computational modeling of behavior, and neuroimaging. The central hypothesis of this proposal is that individuals with PASC will have increased BBB permeability from COVID infection, which disrupts neural processing of effort, resulting in increased feelings of physical fatigue. Aim 1 will determine the relationship between BBB permeability and neural and behavioral representations of effort assessment in individuals with PASC suffering from fatigue. We will collect measures of BBB permeability in PASC patients, have them make assessments of effort, and scan their brains with fMRI while they make these judgments. This data will allow us to study how disruptions in effort assessment are related to COVID-19-induced changes in BBB permeability, and their influence on the neural representations of effort. In Aim 2, we will investigate how BBB permeability influences individuals with PASC's immediate response to bouts of fatiguing exertion and the underlying neural processes. We will have individuals perform bouts of fatiguing exertion and simultaneously scan their brains with fMRI. This data will allow us to study how individuals with PASC's feelings of fatigue (and associated neural activity) evolve, and how COVID-induced increases in BBB permeability mediate these changes. In Aim 3 we will evaluate how BBB permeability changes through the time course of PASC and how these changes are related to behavioral and neural representations of fatigue. Over the course of a year, we will collect measures of BBB permeability in individuals with PASC and have them assess their levels of effort exertion and perform effort-based decision-making tasks while scanned with fMRI. In sum, our proposed studies will provide an understanding of the neurobiological mechanisms of fatigue in PASC. This knowledge will eventually provide candidate mechanisms to target with pharmacological intervention and inform rehabilitative care for those individuals suffering from symptoms of fatigue in PASC.